US$ 24.31
tirzepatide efficacy weight-loss study shows promising results Benefits of Tirzepatide Injections |
Description
It is a triple GIP/GLP-1/glucagon receptor agonist approved for obesity

If you must inject in extreme temperatures, the abdomen is the most temperature-stable injection site because core body temperature fluctuates less than extremity temperature

This dual action is essential for weight loss but can temporarily trigger queasiness as your body adjusts to the medication

J Clin Endocrinol Metabol

Stroman PW, Staud R, Pukall CF
01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)